Literature DB >> 30043690

Interrelationships Among Neuroimaging Biomarkers, Neuropsychological Test Data, and Symptom Reporting in a Cohort of Retired National Football League Players.

Andrew W Kuhn1, Scott L Zuckerman1,2, Gary S Solomon1,2, Ira R Casson3, David C Viano4,5.   

Abstract

BACKGROUND: Structural brain changes, potentially resulting from repetitive brain trauma (RBT), have been correlated with neurocognitive decline and increased symptom reporting in retired athletes. HYPOTHESIS: In a cohort of retired National Football League (NFL) players, the relationships between 3 neuroimaging parameters, neuropsychological testing, and symptom scores will be significantly correlated. STUDY
DESIGN: Cross-sectional study. LEVEL OF EVIDENCE: Level 3.
METHODS: Comprehensive magnetic resonance imaging was performed in 45 retired NFL players. Three neuroanatomical parameters were assessed by board-certified radiologists blinded to the purpose of the study: (1) the absence or presence of small or large cavum septum pellucidum, (2) a global mean score of fractional anisotropy (FA), and (3) the presence or absence of microhemorrhages. The subjects underwent a battery of 9 paper-and-pencil neuropsychological tests, a computerized neurocognitive test, and multiple symptom and depression scales. The associations among the neuroimaging results with these outcome measures were assessed utilizing Pearson, Spearman rank, and point-biserial correlations.
RESULTS: The 45 subjects (mean age, 46.7 ± 9.1 years) reported a mean 6.9 (±6.2) concussions and 13.0 (±7.9) "dings" in the NFL. Ten (22%) did not have a cavum septum pellucidum, while 32 (71%) had a small and 3 (7%) had a large one. Four (9%) had microhemorrhages. Global FA mean was 0.459 (±0.035). The majority (50.8%) of correlations among the neuroimaging parameters and neurocognitive/symptom scores fell below the threshold of "small" effect size ( r < 0.10). The remaining (49.2%) correlations were between "small" and "medium" effect sizes (0.1 < r < 0.3). However, all correlations were statistically nonsignificant.
CONCLUSION: There were minimal and statistically nonsignificant correlations among the neuroimaging, neurocognitive, and symptom scores examined in this cohort of NFL retirees. CLINICAL RELEVANCE: Associating the severity of structural brain changes to neurocognitive performance and symptom burden after RBT is complex may involve other moderating variables or biomarkers, and demands further study.

Entities:  

Keywords:  National Football League; chronic impairment; cognitive function; neuroimaging; neuropsychological testing; neuroradiology; sport-related concussion

Year:  2016        PMID: 30043690      PMCID: PMC5315257          DOI: 10.1177/1941738116674006

Source DB:  PubMed          Journal:  Sports Health        ISSN: 1941-0921            Impact factor:   3.843


The potential long-term effects of repetitive brain trauma (RBT) in American football have taken hold of the national spotlight.[14,35] RBT may occur in the form of concussions and/or subconcussive impacts.[6,43,54] While some reports support a causal link between neurocognitive decline and RBT,[64,65] others have suggested that the evidence is incomplete and that a direct causal link cannot be made at the present time.[11,26,27,62] Neuroimaging and neuropsychological testing represent evolving and commonly used modalities to quantify intracranial neurologic injury. Many different neuroimaging modalities have been utilized to study brain injury. Routine magnetic resonance imaging (MRI) can assess various anatomical parameters, including cortical thinning[34] and cavum septum pellucidum.[20,44] Diffusion tensor imaging (DTI) is a noninvasive MRI method that uses the diffusion properties of water to generate measures of white matter structural integrity within the brain.[68] In particular, fractional anisotropy (FA) and mean diffusivity (MD) measure the directionality and magnitude of water diffusion.[68] Functional MRI can evaluate brain activity in the acute and chronic phases of injury,[1,54,69] and positron emission tomography (PET) can identify protein structures, such as amyloid plaques, which may be suggestive of ongoing neurodegeneration.[47] Utilizing these advanced neuroimaging techniques, several studies have correlated positive neuroimaging findings (thought to result from cumulative RBT) with neurocognitive decline.[23,33,59,66,67,74] As a result, it has become widely accepted that RBT leads to structural brain pathology, which in turn can serve as either an in vivo or postmortem biomarker for clinical diagnoses of abnormal neurobehavioral changes or neurocognitive decline. However, this widely accepted paradigm warrants further study due to limitations inherent to studying RBT, including small sample sizes and the potential for selection bias.[2,61] The purpose of this investigation was to assess the relationships among 3 neuroimaging findings (cavum septum pellucidum, FA global mean, and microhemorrhages) and neuropsychological test performance and symptom endorsement in a relatively large sample of retired National Football League (NFL) athletes. For this initial investigation, based on the prior literature examining retired NFL players,[23,33,66,74] we accepted the hypothesis that the relationships between these neuroimaging parameters and neuropsychological test and symptom scores would be significantly associated, as evidenced by multiple statistically significant correlations.

Methods

Institutional review board approval was granted for the study, and oral and written consent for subjects who met the inclusion and exclusion criteria was obtained by the study coordinator. Data were collected in a confidential manner, deidentified, and aggregated into a Microsoft Excel (Microsoft Inc) spreadsheet. The subjects included in the current study were originally recruited by Casson et al[10] and have subsequently been restudied in a separate independent analysis.[60] We summarize their methodology below.

Subject Recruitment and Inclusionary Criteria

Through the National Football League Players Association (NFLPA), 5000 retired players received recruitment letters explaining the purpose of the original study. The list of players was obtained through the NFL players’ union. A dedicated, confidential telephone number was provided for those who were interested in participating. Additionally, the study coordinator randomly selected names of players on file to call and ask whether they were interested in participation. During the study period, current subjects contacted former teammates, friends, or colleagues who were also retired NFL players who may have been interested in participating. Two former NFL players (4.4%) heard about the study in this manner and were included in the final cohort. Subjects were included only if they were aged 60 years or younger, retired from the NFL, and able to tolerate MRI scanning.

Exclusionary Criteria

Subjects were excluded if they reported meeting any of the following criteria: a history of (1) brain surgery; (2) brain tumor, stroke, multiple sclerosis, or seizures that began prior to entering the NFL (except febrile seizures); (3) HIV or AIDS; (4) significant head injury from automobile accidents or other nonathletic-related trauma to the head resulting in loss of consciousness and/or amnesia and/or hospitalization and/or neurosurgery; (5) concussion/mild traumatic brain injury (mTBI) post–NFL career with minutes of loss of consciousness or hospitalization; (6) open heart surgery, organ transplantation, or carotid artery surgery; (7) treatment with chemotherapy or radiation therapy for cancer affecting the brain or spinal cord; (8) renal failure requiring dialysis or liver failure resulting in cirrhosis or request for liver transplantation; (9) significant alcohol abuse and/or drug abuse in the past or present manifested by having been suspended by a league, arrested for DUI, or treated in a rehabilitation facility for drug or alcohol abuse; (10) daily use of an illegal drug; and (11) daily intake of more than 4 beers or more than 2 “hard liquor” drinks during the past 5 years.[10,60]

History-Taking Procedures, Demographics, and Exposure-Based Information

Medical, social, and familial histories were obtained from each subject. Extensive questioning included: (1) information related to football exposure such as position(s) played, number of concussions, number of “dings” (defined as “a momentary abnormal sensation in the head occurring immediately upon head impact, with complete resolution within a few seconds and no residual effects”[10]), and number of years played at each level; (2) social factors unrelated to football, including post–NFL career employment history, whether public assistance was ever received, annual income, housing status, history of domestic violence incidents, educational history, history of diagnosed attention-deficit hyperactivity disorder or learning disabilities; and (3) pre-NFL details of childhood social situations, including exposure to abuse and/or violence. Additional demographic factors were recorded, including date of birth, height, and weight. All histories were taken individually and in person.

Neuroradiological Outcome Measures

Every subject underwent MRI, consisting of baseline T1, T2, T2* gradient echo, and fluid attenuated inversion recovery (FLAIR) sequences. Susceptibility weighted imaging (SWI) and diffusion tensor imaging (DTI) sequences were also taken.

Cavum Septum Pellucidi

Anatomical MRI interpretations were performed and scored by 2 professor-level, board-certified neuroradiologists who were both blinded to the clinical data on the subjects. The absence or presence of a small or large cavum septum pellucidum was recorded qualitatively for each subject. The results were coded in an ordinal fashion (0 = absent, 1 = small, 2 = large).

Fractional Anisotropy Mean

DTI data were collected with 6 gradient directions uniformly spaced on the surface of a b = 1000 s/mm2 sphere (repetition time [TR]/echo time [TE], 6500 ms/100 ms; voxel size, 2 × 2 × 3 mm3; EPI [echo planar imaging] factor, 96; time duration, 7 minutes and 43 seconds). A global white matter FA mean analysis was performed for each subject using an approach known to be sensitive to mTBI.[8]

SWI Microbleeds

The SWI sequence consisted of a strongly susceptibility weighted, low bandwidth (80 Hz/pixel) 3D FLASH sequence (TR/TE, 50 ms/40 ms; FA, 15°), with first-order flow compensated in all 3 orthogonal directions.[72] Mean acquisition time was 7 minutes and 42 seconds. Regions analyzed included the cerebral hemispheres and posterior fossa. A neuroradiologist and MR scientist, each with more than 3 decades of clinical experience, were blinded to the specifics of this study and reviewed these data. Potential lesions were confirmed by both, and the total number and volume of these hemorrhagic lesions (microbleeds) were quantified and analyzed utilizing developed software from the MRI Institute for Biomedical Research Signal Processing for NMR [SPIN]. SWI data were coded dichotomously as either the presence or absence of microbleeds.

Neuropsychological Testing and Depression Scale Outcome Measures

Paper-and-Pencil Neuropsychological Tests

A committee of 5 members of the National Academy of Neuropsychology (3 of whom were not affiliated with the NFL or any of its teams) constructed a battery of paper-and-pencil neuropsychological tests designed to measure the following cognitive domains: verbal and visual memory, executive functioning, psychomotor speed, sustained attention, working memory, and estimated premorbid verbal IQ. These tests included the following: the Test Of Memory Malingering (TOMM)[71]; the Brief Visuospatial Memory Test–Revised (BVMT-R) Sum of trials 1-3 and Delayed Recall[7]; the California Verbal Learning Test–Second Edition (CVLT-II), including short delay and long delay free recall[15]; Trail Making Tests A and B (Trails A and Trails B)[50]; Wechsler Adult Intelligence Scale–Third Edition (WAIS-3) Digit Symbol and Letter Number Sequencing subtests[77]; Controlled Word Association Test (COWAT; letters FAS)[39]; Category Fluency (Animals); and the Wechsler Test of Adult Reading (WTAR IQ).[78] The paper-and-pencil neurocognitive tests were administered and scored in accordance with standard neuropsychometric procedures by a licensed, doctoral-level clinical neuropsychologist.

Immediate Postconcussion Assessment and Cognitive Testing (ImPACT)

ImPACT (ImPACT Applications, Inc),[40] a commonly used computerized neurocognitive test for neurocognitive assessment in sport-related concussion, was also administered. ImPACT was designed to measure cognitive functioning across 6 testing modules assessing attention, memory, reaction time, and processing speed. Numerical composite scores are computed for the domains of verbal memory, visual memory, visual motor (processing) speed, reaction time, and impulse control. A registered nurse supervised all computerized testing sessions.

Depression and Symptom Scales

ImPACT also contains a section for demographic information and a symptom assessment scale, which includes 22 commonly reported concussion symptoms, each rated from 0 to 6 based on severity.[41] In addition, the Beck Depression Inventory–II (BDI-II),[5] Patient Health Questionnaire (PHQ),[42,63] and Mini-Mental State Examination (MMSE)[19] were also administered to measure current self-reported depressive and other neuropsychiatric symptoms in subjects.

Statistical Analyses

Deidentified data were imported into a Microsoft Excel spreadsheet. Descriptive statistics were calculated for all demographic, structural brain imaging, and neurocognitive/symptom scores as either a mean and standard deviation (SD) or counted as n (%). Each neurocognitive test or depression/neuropsychiatric symptom score was then correlated with structural imaging data by Pearson (FA mean), point-biserial (microbleeds), and Spearman rank (cavum septum pellucidum) correlations. In instances where outcome data were nonnormally distributed (as determined by Shapiro-Wilk tests for normality), Spearman rank correlations were used. All statistics were computed at the 95% confidence interval level via the statistical software program SPSS (version 22.0; IBM Corp).[25]

Results

Descriptive Statistics

Demographic and exposure-based characteristics pertaining to the 45 subjects analyzed in this study can be found in Table 1.
Table 1.

Demographic characteristics of 45 retired National Football League (NFL) players[ ]

CharacteristicMean (±SD) or n (%)
Age, y46.7 (±9.1)
Height, in75.0 (±1.8)
Weight, lb254.9 (±45.9)
Body mass index31.4 (±4.8)
Learning disability10 (22.2)
NFL position
 Quarterback0 (0)
 Runningback/fullback2 (4)
 Wide receiver2 (4)
 Tight end1 (2)
 Offensive lineman9 (20)
 Defensive lineman9 (20)
 Safety/cornerback9 (18)
 Linebacker14 (32)
Football experience, y
 Pre–high school2.5 (±2.3)
 High school and college7.7 (±1.0)
 NFL training camp6.8 (±3.2)
Played other contact sports5 (11)
Prior sport-related concussion
 Football9.0 (±6.9)
 NFL6.9 (±6.2)
Prior sport-related “dings”
 Football14.9 (±7.9)
 NFL13.0 (±7.9)
Nonsport-related head injury
 Concussion0.2 (±0.4)
 Other head injury0.1 (±0.3)
Alcohol or drug suspension0 (0)

Reprinted with permission from Solomon et al.[60]

Demographic characteristics of 45 retired National Football League (NFL) players[ ] Reprinted with permission from Solomon et al.[60]

Correlations Among Neuroimaging Findings, Neuropsychological Test Performance, and Depression and Symptom Scores

Interpretations of the distributions of neuropsychological testing, depression, and total symptom scores have been described in detail in a previous study.[10] Outcomes are reprinted in Table 2. In general, these paper-and-pencil neuropsychological test scores were normally distributed. Shapiro-Wilk tests for normality demonstrated that for 4 (33%) of the 12 scores, BVMT delay (P = 0.02), Trails B (P = 0.016), FAS (P = 0.008), and WTAR IQ (P = 0.031) did not follow a pattern of normal distribution. Further, ImPACT reaction time (P < 0.001) and impulse control (P < 0.001) composite scores were not normally distributed. None of the symptom scale scores were normally distributed and displayed positively skewed distributions (ie, the mean was greater than the median) except for MMSE, which displayed negative skewness. For these outcome measures, Spearman rank correlations were utilized.
Table 2.

Structural brain imaging, neuropsychological testing, and depression and symptom scores in 45 retired National Football League players[ ]

OutcomeMean (±SD) or n (%)
Structural brain imaging
Cavum septum pellucidum
 Absent10 (22)
 Small32 (71)
 Large3 (7)
SWI microbleeds4 (9)
FA mean0.459 (±0.035)
Neuropsychological testing
Brief visuospatial memory test—sum43.0 (±10.9)
Brief visuospatial memory test—delayed recall49.4 (±11.0)
California Verbal Learning Test—sum39.1 (±9.2)
California Verbal Learning Test—short delay free recall39.5 (±10.4)
California Verbal Learning Test—long delay free recall38.4 (±8.6)
Trails A51.1 (±10.8)
Trails B46.5 (±8.0)
Controlled Oral Word Association Test—FAS47.9 (±9.0)
Animals50.2 (±9.6)
Wechsler Adult Intelligence Scale—Digit Span47.7 (±8.9)
Wechsler Adult Intelligence Scale—Letter Numbering Sequence50.6 (±8.9)
Wechsler Test of Adult Reading—Intelligence Quotient98.6 (±12.3)
ImPACT verbal memory75.9 (±12.0)
ImPACT visual memory59.0 (±14.0)
ImPACT visual motor processing speed28.6 (±8.3)
ImPACT reaction time0.77 (±0.19)
ImPACT impulse control5.70 (±6.0)
Depression and symptom scales
Beck Depressive Inventory–II9.71 (±9.6)
Mini-Mental State Examination28.5 (±1.3)
Patient Health Questionnaire26.5 (±19.9)
ImPACT Total Symptom Score20.0 (±21.3)

FA, fractional anisotropy; ImPACT, Immediate Post-Concussion Assessment and Cognitive Testing; SWI, susceptibility weighted image; Trails A and B, Trail Making Tests A and B.

Reprinted with permission from Solomon et al.[60]

Structural brain imaging, neuropsychological testing, and depression and symptom scores in 45 retired National Football League players[ ] FA, fractional anisotropy; ImPACT, Immediate Post-Concussion Assessment and Cognitive Testing; SWI, susceptibility weighted image; Trails A and B, Trail Making Tests A and B. Reprinted with permission from Solomon et al.[60] In terms of neuroradiological findings, 10 subjects (22%) did not have a cavum septum pellucidum, 32 (71%) had a small one, and 3 (7%) presented with a large one. Four (9%) of the subjects had microbleeds present, and average FA mean was 0.459 (±0.035). For 1 subject, FA mean was discarded for technical reasons, thus these correlations had 1 less degree of freedom (n = 44). The distributions of neuroimaging results are presented in Figure 1. Interpretations of the distribution of these neuroimaging findings have been described in a previous study.[10]
Figure 1.

Distribution of neuroimaging biomarkers of (a) cavum septum pellucidum, (b) fractional anisotropy, and (c) microbleeds in 45 retired National Football League players.

Distribution of neuroimaging biomarkers of (a) cavum septum pellucidum, (b) fractional anisotropy, and (c) microbleeds in 45 retired National Football League players. None of the correlations among neuroimaging and neurocognitive functioning reached a conventional level of statistical significance (Table 3). A post hoc adjustment for multiple comparisons was not needed as none of the values reached the a priori level of statistical significance (P = 0.05).
Table 3.

Overall correlations among structural brain imaging findings, neuropsychological testing performance, depressive and total symptom scores in retired National Football League athletes[ ]

Structural Brain Imaging
SWI Microbleeds (n = 45)FA Mean (n = 44)Cavum Septum Pellucidum (n = 45)
Neuropsychological testing
 Brief visuospatial memory test sum−0.077 (0.617)0.098 (0.528)−0.043 (0.779)
 Brief visuospatial memory test—delayed recall−0.123 (0.419)0.011 (0.941)0.068 (0.657)
 California Verbal Learning Test—sum−0.236 (0.119)−0.250 (0.101)−0.172 (0.259)
 California Verbal Learning Test—short delay free recall−0.128 (0.403)−0.178 (0.247)−0.176 (0.247)
 California Verbal Learning Test—long delay free recall−0.113 (0.458)−0.212 (0.168)−0.154 (0.312)
 Trails A0.035 (0.822)0.043 (0.780)0.042 (0.783)
 Trails B−0.021 (0.891)0.053 (0.732)−0.077 (0.617)
 Controlled Oral Word Association Test—FAS0.247 (0.102)0.146 (0.343)0.125 (0.412)
 Animals−0.048 (0.755)0.039 (0.803)0.089 (0.561)
 Wechsler Adult Intelligence Scale—Digit Span0.020 (0.896)0.138 (0.371)0.196 (0.196)
 Wechsler Adult Intelligence Scale—Letter Numbering Sequence−0.046 (0.762)0.071 (0.647)−0.110 (0.471)
 Wechsler Test of Adult Reading—Intelligence Quotient0.027 (0.860)−0.003 (0.982)−0.106 (0.487)
 ImPACT verbal memory−0.235 (0.120)−0.135 (0.381)−0.108 (0.482)
 ImPACT visual memory0.045 (0.768)0.033 (0.831)−0.101 (0.508)
 ImPACT visual motor processing speed0.063 (0.679)0.151 (0.329)0.011 (0.943)
 ImPACT reaction time0.093 (0.542)−0.014 (0.930)−0.082 (0.593)
 ImPACT impulse control0.024 (0.875)−0.014 (0.926)−0.109 (0.475)
Depression and symptom scales
 Beck Depressive Inventory–II0.009 (0.953)0.048 (0.757)0.103 (0.502)
 Mini-Mental State Examination−0.257 (0.089)−0.218 (0.156)−0.132 (0.388)
 Patient Health Questionnaire0.175 (0.251)0.231 (0.131)0.173 (0.256)
 ImPACT Total Symptom Score0.106 (0.490)0.028 (0.855)0.056 (0.715)

FA, fractional anisotropy; ImPACT, Immediate Post-Concussion Assessment and Cognitive Testing; SWI, susceptibility weighted image; Trails A and B, Trail Making Tests A and B.

Data are presented as r/r (P value).

Overall correlations among structural brain imaging findings, neuropsychological testing performance, depressive and total symptom scores in retired National Football League athletes[ ] FA, fractional anisotropy; ImPACT, Immediate Post-Concussion Assessment and Cognitive Testing; SWI, susceptibility weighted image; Trails A and B, Trail Making Tests A and B. Data are presented as r/r (P value). Cohen delineated correlative r values of 0.10, 0.30, and 0.50 as “small,” “medium,” and “large” effect sizes, respectively.[12] According to these values, the majority (50.8%) of the correlations obtained in this study were below the threshold of a small effect size. The remaining (49.2%) fell in between small and medium effect sizes (Figure 2). While these reference values have served as the gold standard across many clinical health disciplines, effect sizes should always be interpreted in accordance with the measurements taken, data analyzed, and clinical importance of the study.[16] In many instances, another understanding of effect size is the r2 value, which calculates the amount of variance observed in the outcome variable accounted for by the (independent) predictor variable. In the current study, the presence or absence of microhemmorhages accounted for between 0.04% and 6.10% of the variance observed across neurocognitive functioning and between 0.008% and 6.53% of the variance seen in reported symptoms. FA global mean values accounted for between 0.0009% and 6.25% of the variance observed across neurocognitive functioning and between 0.078% and 5.33% of the variance seen in reported symptoms. Last, the absence or presence of a small or a large cavum septum pellucidum accounted for between 0.17% and 3.84% of the variance observed across ranked neurocognitive functioning and between 0.31% and 2.99% of the variance observed in ranked reported symptoms. For the purposes of contextual reference, an independent variable accounting for 1% to 9% of the variance observed in the dependent variable could be classified as small to medium effect size.[12]
Figure 2.

Frequency of absolute correlative r values and Cohen effect sizes among the 3 neuroimaging biomarkers and 63 neuropsychological testing and symptom endorsement outcome measures analyzed.

Frequency of absolute correlative r values and Cohen effect sizes among the 3 neuroimaging biomarkers and 63 neuropsychological testing and symptom endorsement outcome measures analyzed.

Discussion

Assessment of cavum septum pellucidum, FA global mean score, and microbleed data yielded no significant associations with several measure of neurocognitive functioning, including 9 paper-and-pencil tests (yielding 12 scores), a computerized neuropsychological test (yielding 5 scores), and 4 scales of depressive and other neuropsychiatric symptoms.

Cavum Septum Pellucidum

The prevalence of cavum septum pellucidum ranges widely, from as low as 0.73% to as high as 60.3% in pediatric and adults populations because of selection bias and different imaging and measuring techniques.[9,18,37,48,51,53,57,58,70] However, this structural abnormality has been commonly associated with conditions such as schizophrenia, bipolar disorder, seizures, developmental/intellectual disabilities, stroke and cranial nerve abnormalities, and head trauma.[31,51,53] After the publication of the classic 1973 neuropathological description of the cardinal features of chronic traumatic encephalopathy (CTE) in boxers by Corsellis et al,[13] it is widely accepted that abnormalities of the septal region (large cavum septum pellucidum) can serve as structural hallmarks of CTE. Imaging studies have subsequently revealed that cavum septum pellucidum is highly prevalent in retired boxers.[9,45] Recent neuropathology studies have reported large cavum septum pellicidum in some, but not all, cases of putative CTE in American football players.[45] In a case-control study, retired professional football players had cavum septum pellucidum more frequently with a significantly higher grade and measured length than their age-/sex-matched counterparts.[20] However, the current analysis yielded only 7% of players having a large cavum septum pellucidum. Regardless, this structural abnormality and its direct implications in neurobehavioral changes and neuropsychiatric functioning in retired football players remains to be clarified. The most recent exploration on the role of septal abnormalities was in 2016; 72 former NFL players (age range, 40-69 years) were compared on neuroradiological and neuropsychological testing data to 14 unmatched former athlete controls who had played at least 2 years of noncontact sports at the collegiate level and had no history of concussion.[33] After controlling for confounders (body mass index, age, years of education, and years playing football), cavum septum pellucidum was more frequent in the NFL group versus controls. In addition, the mean length of cavum septum pellucidum was greater in the NFL group than the control group. The results of cavum septum pellucidum length in the NFL group were then correlated with behavioral measures. The cavum septum pellucidum length was dichotomized into 2 groups (≥6 mm and ≤2 mm), and those in the ≥6-mm group displayed lower scores on 2 neurocognitive tests (NAB List A Immediate Recall and WRAT-4 Reading Test). Between-group differences across the other 22 outcome measures (91.7%) were nonsignificant. Effect sizes were not reported. The authors concluded that cavum septum pellucidum was associated with lower verbal memory and word pronunciation, but that true clinical significance is difficult to gauge without effect sizes.[33] In addition, the WRAT-4 is most often used as a measure of premorbid cognitive ability, and its appropriateness in assessing the potential long-term effects of RBT is questionable.[36] The results of the current study lend credence to the hypothesis that the ordinal ranking of cavum septum pellucidum may contribute only minimally to performance on a comprehensive battery of neurocognitive and neurobehavioral measures in retired NFL players. However, given the variable findings previously, future study is warranted.

Fractional Anisotropy

FA provides an index of white matter structure and integrity by measuring directionality of water motion.[29,49] FA is sensitive to the acute phases of mTBI and has utility in studying the intermediate- and long-term structural effects of RBT.[17] In patients without a history of head trauma (mean age, 27.5 years), global FA mean was 0.431.[8] While direct comparisons are difficult to gauge because of possible age-related differences, in this cohort of retired NFL athletes, global FA mean was measured as 0.459 and significantly associated with number of NFL concussions.[10] A small preliminary study of younger athletes who had sustained RBT found that white matter changes, while evident, were not correlated with cognitive test performance. Ten Division III collegiate football players and 5 nonathlete controls were examined during the preseason, immediate postseason, and 6 months after no-contact rest in the postseason.[4] Decreased FA was observed between preseason and postseason and correlated with RBT, but white matter changes were not consistently associated with cognition or balance, as assessed by a computerized neurocognitive test (ImPACT) and the Balance Error Scoring System (BESS), respectively. While this is an important pilot study, the results are limited by sample size and a small battery of measurement instruments such that generalizing to a larger group would be premature. Similarly, 16 university ice hockey players with a history of concussion were compared with 18 players without a history of concussion and it was found that in the concussed group, there were specific cerebral regions (right posterior limb of the internal capsule, right corona radiata, and right temporal lobe) with significant increases in FA, which were not found in the nonconcussed athletes.[56] However, these imaging features did not correlate with computerized neurocognitive (ImPACT) or Sport Consussion Assessment Tool–2 (SCAT2) scores (the latter including measures of balance and cognition, as well as symptoms). When examining older, retired athletes, as in the current study, correlations have been found between FA and neurocognitive functioning. In a cohort of 26 retired NFL athletes, 5 had depression on BDI-II and 22 controls had FA data with BDI-II scores correlated.[65] There were no significant differences in FA between healthy controls and nondepressed retired athletes. In the entire 26-athlete cohort, 4 white matter tracts (forceps minor, right uncinate fasciculus, right frontal aslant tract, and left superior longitudinal fasciculus) displayed depressed FA mean values that were significantly associated with increased total BDI-II scores. The 16 other (80%) white matter tracts displayed negative correlations with BDI-II scores but were statistically nonsignificant. In a separate cross-sectional analysis, 34 retired NFL athletes were compared with age-matched (mean age, 61.8 years) and estimated IQ-matched controls.[23] The symptomatic retired athletes demonstrated widely distributed reductions of FA in frontal and parietal regions bilaterally as well as along the corpus callosum and in the left temporal lobe. Comparisons were made between cognitively impaired athletes (n = 10) and matched controls (n = 10) as well as between depressed athletes (n = 6) and matched controls (n = 6). Both comparisons showed widely distributed voxels with lower FA in the symptomatic (cognition or mood) athlete groups. Retired NFL players without cognitive impairment or depression did not demonstrate white matter abnormalities compared with controls. However, common to most studies analyzing retired NFL players, this study was small. Last, 15 retired collegiate athletes (mean age, 60.9 years) with a history of concussion and who were otherwise clinically normal (no other comorbidities) were examined and compared with 15 age- and education-matched controls.[74] The majority (70%) of these were former ice hockey players and the remainder (30%) were American football players, all university-level. The concussion group had decreases in FA in the frontoparietal networks and the frontal aspects of the corpus callosum. These white matter abnormalities were significantly associated with a decrease in episodic visual memory (delayed recall of the Taylor Complex Figure Test). They suggested that their results fit better with changes seen in normal aging, and that perhaps a history of concussion may cause these effects to be expedited, concluding, “the nature of interaction between ageing and a history of concussions involves a latent microstructural injury that leaves the brain more vulnerable to the deleterious effects of ageing.”[74] In this analysis, FA global mean values accounted for 0.0009% to 6.25% of the variance observed across neurocognitive test performance and between 0.078% and 5.33% of the variance seen in reported symptoms. While rendering the strongest correlation across all outcome measures with CVLT-II sum of trials (r = −0.250, P = 0.101), this relationship was statistically nonsignificant and did not reach the traditional definition of medium effect size. Research supports a relationship between RBT and chronic white matter structural changes; however, its direct relationship to neurobehavioral changes and neuropsychiatric disorders remains limited, and at present, is without a proven causative relationship.

Microhemorrhages

In healthy adults (age range, 52.9-64.4 years), the prevalence of cerebral microhemorrhaging ranges from 3.1% to 6.4%,[28,55,75] but is reported as high as 56.0% in patients who are hypertensive.[38,76] While microhemorrhages or microbleeds can be attributed to amyloid angiopathy and/or hypertension, in otherwise healthy patients younger than 60 years, it is more likely the result of head trauma with a rotational shear mechanism of injury.[3,10,21,32] A prior study examining these same retired NFL athletes reported that the presence of microbleeds was low (9%) but positively correlated with reported “number of dings” (“abnormal sensation in the head occurring immediately upon head impact, with complete resolution within a few seconds and no residual effects”).[10] There have been higher rates of cerebral microhemorrhaging reported in boxers when compared with control subjects, yet these comparisons have rendered statistically nonsignificant results.[22,24] In the current study, the presence of microbleeds was not associated with any neurocognitive test performance or neuropsychiatric symptom outcome measure and accounted for between 0.008% and 6.53% of the variance observed across these measures.

Direction for Future Study

Assessment of correlations among 3 structural imaging parameters with multiple indices of neurocognitive functioning and symptoms in a group of retired NFL players yielded nonsignificant results. Future study is needed to elucidate more completely the relationships among structural imaging, neurocognitive test performances, and neurobehavioral functioning in retired athletes exposed to RBT and in those with documented brain trauma. It may be the case that RBT can have a cumulative effect on some structural anatomical parameters, but these changes in relation to neurocognitive and neurobehavioral functioning remain unclear. Conceivably, comorbid health conditions and lifestyle factors may be moderating variables. Given the nature of studying retired professional athletes, most studies have suffered from small sample sizes, varying ages of subjects, and sample convenience. Age is a critical factor in metabolic and structural brain changes and must be taken into account when evaluating the results of various studies. Furthermore, caution must be employed in the interpretation of conclusions published, as some conclusions have been proclaimed as significant yet perhaps overgeneralized (ie, where a single neuropsychological test is deemed to be representative of an entire cognitive domain) when the results obtained may have in actuality been due to a variety of other factors not limited to imprecision of the measures utilized and/or by chance of multiple testing. For instance, across a large battery of neuropsychological tests, statistical significance might be obtained with only 1 or a small proportion of tests or subtests.[33] Additionally, in this study, “total symptom score” was used as an outcome measure when others have suggested that a 2- or 3-factor analysis approach to symptom scores should be used.[30,52] The current study is not without other limitations. This was a cross-sectional study of a relatively large NFL sample (45 subjects) but did not include a control group. In addition, the subjects in the current study were younger than 60 years, and therefore, these results cannot be generalized to retired NFL athletes older than 60 years. Although strict inclusion and exclusion criteria were utilized, subjects were not selected randomly, and the final sample was one of convenience, indicating selection bias as a possible confounder. In addition, variance in the structural parameters may have been truncated, as only 4 (9%) of the 45 players had microhemmorhages present. Although a shortcoming of most studies of sport-related concussion, concussion histories and other historical data were self-reported and not documented or corroborated by medical records. Only 3 neuroimaging outcome measures were examined (1 of which was recorded qualitatively), and other structural neuroimaging biomarkers implicated in RBT in prior studies (eg, lateral ventricle, hippocampal, and cortical volumes[46,59,67,73]) may be of greater value in assessing these presumed brain-behavior relationships. Additionally, there were 2 neuroradiologists who made neuroanatomical measurements. While they agreed on all measurements of cavum septum pellicidum, a formal interrater reliability procedure or calculation was not conducted. Finally, while nonsignificant, these results are measures of correlation and not causation, and should be taken in that light.

Conclusion

In a relatively large sample of retired NFL players, across 9 paper-and-pencil neuropsychological tests (yielding 12 measures), a computerized neuropsychological test (yielding 5 composite scores), and 4 scales of mood and other neuropsychiatric functions, the MRI measures of cavum septum pellucidum, FA mean, and microhemorrhaging accounted for between 0.0009% and 6.53% of the variance observed. While a well-respected and often-utilized paradigm, concluding that in vivo structural brain changes are the direct cause of specific neuropsychiatric symptomatology after chronic RBT is a complex endeavor and requires further study. Future efforts in disentangling the relationships among neuroimaging parameters and neurocognitive functioning will require prospective studies of larger samples of retired professional football players across various age ranges, with clear inclusion/exclusion criteria; multimodal and comprehensive neuroimaging, neurocognitive, and neuropsychiatric test measures; access to actual historical concussion and medical records data; thorough personal biopsychosocial data; family history information; and perhaps genetic markers. Although highly aspirational, definitive conclusions will require studies of this magnitude and depth to address the matter empirically.
  66 in total

1.  CONGENITAL DILATATIONS OF THE SEPTUM PELLUCIDUM.

Authors:  H SCHUNK
Journal:  Radiology       Date:  1963-10       Impact factor: 11.105

Review 2.  Cerebral microhemorrhage.

Authors:  Anand Viswanathan; Hugues Chabriat
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

Review 3.  Chronic effects of mild neurotrauma: putting the cart before the horse?

Authors:  Rudy J Castellani; George Perry; Grant L Iverson
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

4.  FMRI hypoactivation during verbal learning and memory in former high school football players with multiple concussions.

Authors:  Douglas P Terry; T Eric Adams; Michael S Ferrara; L Stephen Miller
Journal:  Arch Clin Neuropsychol       Date:  2015-04-22       Impact factor: 2.813

5.  The role of location of subconcussive head impacts in FMRI brain activation change.

Authors:  Meghan E Robinson; Trey E Shenk; Evan L Breedlove; Larry J Leverenz; Eric A Nauman; Thomas M Talavage
Journal:  Dev Neuropsychol       Date:  2015       Impact factor: 2.253

Review 6.  Chronic traumatic encephalopathy and the availability cascade.

Authors:  Gary S Solomon; Allen Sills
Journal:  Phys Sportsmed       Date:  2014-09       Impact factor: 2.241

7.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

8.  Alteration of default mode network in high school football athletes due to repetitive subconcussive mild traumatic brain injury: a resting-state functional magnetic resonance imaging study.

Authors:  Kausar Abbas; Trey E Shenk; Victoria N Poole; Evan L Breedlove; Larry J Leverenz; Eric A Nauman; Thomas M Talavage; Meghan E Robinson
Journal:  Brain Connect       Date:  2014-10-21

9.  Relationship of collegiate football experience and concussion with hippocampal volume and cognitive outcomes.

Authors:  Rashmi Singh; Timothy B Meier; Rayus Kuplicki; Jonathan Savitz; Ikuko Mukai; LaMont Cavanagh; Thomas Allen; T Kent Teague; Christopher Nerio; David Polanski; Patrick S F Bellgowan
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

Review 10.  Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE.

Authors:  Mark Sundman; P Murali Doraiswamy; Rajendra A Morey
Journal:  Front Neurosci       Date:  2015-09-24       Impact factor: 4.677

View more
  8 in total

1.  Estimated Age of First Exposure to American Football and Neurocognitive Performance Amongst NCAA Male Student-Athletes: A Cohort Study.

Authors:  Jaclyn B Caccese; Ryan M DeWolf; Thomas W Kaminski; Steven P Broglio; Thomas W McAllister; Michael McCrea; Thomas A Buckley
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

2.  Prevalence and Incidence of Microhemorrhages in Adolescent Football Players.

Authors:  B R Shah; J M Holcomb; E M Davenport; C M Lack; J M McDaniel; D M Imphean; Y Xi; D A Rosenbaum; J E Urban; B C Wagner; A K Powers; C T Whitlow; J D Stitzel; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2020-07       Impact factor: 3.825

3.  History of Sport-Related Concussion and Long-Term Clinical Cognitive Health Outcomes in Retired Athletes: A Systematic Review.

Authors:  Joice Cunningham; Steven P Broglio; Megan O'Grady; Fiona Wilson
Journal:  J Athl Train       Date:  2020-01-14       Impact factor: 2.860

4.  Quantifying and Examining Reserve in Symptomatic Former National Football League Players.

Authors:  Éimear M Foley; Yorghos Tripodis; Eukyung Yhang; Inga K Koerte; Brett M Martin; Joseph Palmisano; Nikos Makris; Vivian Schultz; Chris Lepage; Marc Muehlmann; Paweł P Wróbel; Jeffrey P Guenette; Robert C Cantu; Alexander P Lin; Michael Coleman; Jesse Mez; Sylvain Bouix; Martha E Shenton; Robert A Stern; Michael L Alosco
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

5.  Multimodal Imaging of Retired Professional Contact Sport Athletes Does Not Provide Evidence of Structural and Functional Brain Damage.

Authors:  Robert Zivadinov; Paul Polak; Ferdinand Schweser; Niels Bergsland; Jesper Hagemeier; Michael G Dwyer; Deepa P Ramasamy; John G Baker; John J Leddy; Barry S Willer
Journal:  J Head Trauma Rehabil       Date:  2018 Sep/Oct       Impact factor: 2.710

Review 6.  Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.

Authors:  Michael L Alosco; Julia Culhane; Jesse Mez
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

7.  Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.

Authors:  Michael L Alosco; Megan L Mariani; Charles H Adler; Laura J Balcer; Charles Bernick; Rhoda Au; Sarah J Banks; William B Barr; Sylvain Bouix; Robert C Cantu; Michael J Coleman; David W Dodick; Lindsay A Farrer; Yonas E Geda; Douglas I Katz; Inga K Koerte; Neil W Kowall; Alexander P Lin; Daniel S Marcus; Kenneth L Marek; Michael D McClean; Ann C McKee; Jesse Mez; Joseph N Palmisano; Elaine R Peskind; Yorghos Tripodis; Robert W Turner; Jennifer V Wethe; Jeffrey L Cummings; Eric M Reiman; Martha E Shenton; Robert A Stern
Journal:  Alzheimers Res Ther       Date:  2021-08-12       Impact factor: 8.823

8.  Examining for Cavum Septum Pellucidum and Ventricular Enlargement in Retired Elite-Level Rugby League Players.

Authors:  Peter Stanwell; Grant L Iverson; Ryan Van Patten; Rudolph J Castellani; Paul McCrory; Andrew J Gardner
Journal:  Front Neurol       Date:  2022-04-06       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.